Welcome to our dedicated page for CoreWeave news (Ticker: CRWV), a resource for investors and traders seeking the latest updates and insights on CoreWeave stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CoreWeave's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CoreWeave's position in the market.
CoreWeave, the AI Hyperscaler™, has announced the pricing of its Initial Public Offering (IPO) at $40.00 per share. The offering comprises 37,500,000 shares of Class A common stock, with 36,590,000 shares offered by CoreWeave and 910,000 shares by existing stockholders.
Trading is set to commence on March 28, 2025, on the Nasdaq Global Select Market under the ticker symbol 'CRWV'. The offering is expected to close on March 31, 2025. CoreWeave has granted underwriters a 30-day option to purchase up to an additional 5,625,000 shares.
The IPO is led by joint bookrunners Morgan Stanley, J.P. Morgan, and Goldman Sachs, with several other prominent financial institutions serving as joint bookrunners and co-managers.
